Erythropoietin as a new therapeutic opportunity in brain inflammation and neurodegenerative diseases.
about
Isoforms of the Erythropoietin receptor in dopaminergic neurons of the Substantia Nigra.Hematopoietic cytokines as therapeutic players in early stages Parkinson's disease.Erythropoietin reduces experimental autoimmune encephalomyelitis severity via neuroprotective mechanisms.Erythropoietin attenuates motor neuron programmed cell death in a burn animal model.The Anti-Aging Effect of Erythropoietin via the ERK/Nrf2-ARE Pathway in Aging Rats.Erythropoietin attenuates axonal injury after middle cerebral artery occlusion in mice.
P2860
Erythropoietin as a new therapeutic opportunity in brain inflammation and neurodegenerative diseases.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh
2014年學術文章
@zh-hant
name
Erythropoietin as a new therap ...... nd neurodegenerative diseases.
@en
type
label
Erythropoietin as a new therap ...... nd neurodegenerative diseases.
@en
prefLabel
Erythropoietin as a new therap ...... nd neurodegenerative diseases.
@en
P2860
P921
P1476
Erythropoietin as a new therap ...... and neurodegenerative diseases
@en
P2093
P2860
P304
P356
10.3109/00207454.2014.989321
P50
P577
2015-01-09T00:00:00Z